Stories > Anocca Appoints Martin Welschof to Board of Directors

Anocca Appoints Martin Welschof to Board of Directors

AB-2100 Phase 1/2 Trial Initiated

Adagene Advances Clinical Collaboration

Advancements in Cancer Treatment and Mar...

Advancing CD70 Targeted Cancer Treatment...

Affini-T Therapeutics at J.P. Morgan Hea...

Anktiva Boosts Lung Cancer Treatment